Detalhe da pesquisa
1.
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
N Engl J Med
; 387(9): 810-823, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053506
2.
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis.
Clin Infect Dis
; 78(3): 730-741, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874021
3.
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
N Engl J Med
; 382(10): 893-902, 2020 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130813
4.
Evaluation of the pharmacokinetic interaction between repeated doses of rifapentine or rifampin and a single dose of bedaquiline in healthy adult subjects.
Antimicrob Agents Chemother
; 59(2): 1219-24, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25512422
5.
Effect of a high-calorie, high-fat meal on the bioavailability and pharmacokinetics of PA-824 in healthy adult subjects.
Antimicrob Agents Chemother
; 57(11): 5516-20, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23979737
6.
Evaluation of pharmacokinetic interaction between PA-824 and midazolam in healthy adult subjects.
Antimicrob Agents Chemother
; 57(8): 3699-703, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23689718
7.
Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis.
Antimicrob Agents Chemother
; 57(5): 2199-203, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23459487